Mechanism: Injected subcutaneously (under the skin) into the abdomen, thigh, or upper arm
By modifying the base molecular structure to resist rapid degradation by the DPP-4 enzyme, scientists have created a compound that remains active for significantly longer periods than native GLP-1
While AOD-9604 has shown minimal interactions in studies, individual situations vary, particularly when multiple medications are involved
Highland Longevity publishes its specific compound list rather than hiding behind custom protocols language, which makes it easier for patients to confirm whether the clinic actually carries what they need
This led Omada and Express Scripts to theorize that with behavior change support through the Omada for Prevention program, individuals taking GLP-1s for weight loss would see greater success
Novo Nordisk has warned it does not support off-label prescribing, which can limit supply for type 2 diabetes patients who have been prescribed the medication